Liposomes as pharmaceutical drug carriers were developed to increase antitumour efficacy and decrease drug toxicity. Doxorubicin HCl liposomal injection was the first liposomal encapsulated anticancer drug to receive clinical approval. To date, virtually all traditional anticancer drugs have been encapsulated in liposomes. The majority of clinical studies only support the concept of a decreased...

The issues of solubility for the targeted drug delivery new affects, many existing drug. minimum 40% novel from pharmaceutical industries are showing poor ability solubilization in water. Hence to increase such waters and their bioavailabilities major challenges scientists. So overcome problems dissolution, development solid dispersion with carriers having good water is beneficiary. methods fou...

The central nervous system disorders represent a worldwide public health problem. Neuro-degeneration is associated with many transitions in brain including synaptic disorder and neuro-cognition decline. It shielded by barrier which controls the entry of compounds into known as blood (BBB), there regulating homeostasis. In achieving therapeutic amount drug to proper site action body then maintai...

Nitrofurazone (NTZ) is usually employed in the topical treatment of infected wounds and lesions of both skin and mucosa. Microencapsulation is a process utilized in the incorporation of active ingredients within polymers aiming at, among other objectives, the prolonged release of pharmaceutical compounds and protection from atmospheric agents (viz. moisture, light, heat and/or oxidation). With ...

Cytotoxicity, low water solubility, rapid clearance from circulation, and off-target side-effects are common drawbacks of conventional small-molecule drugs. To overcome these shortcomings, many multifunctional nanocarriers have been proposed to enhance drug delivery. In concept, multifunctional nanoparticles might carry multiple agents, control release rate, biodegrade, and utilize target-media...

To date, little is known about how neurodegeneration and neuroinflammation propagate in Huntington's disease (HD). Unfortunately, no treatment is available to cure or reverse the progressive decline of function caused by the disease, thus considering HD a fatal disease. Mutation gene carriers typically remain asymptomatic for many years although alterations in the basal ganglia and cortex occur...

BACKGROUND AND OBJECTIVES Many researchers in the last four decades have been devoted to the development of drug-delivery systems. Since its first application in the pharmaceutical industry, many results have been obtained especially in the molecular manipulation of carriers and their interaction with encapsulated drugs. These new carriers have the advantage of bypassing encapsulated drugs rest...

A variety of nano-carriers, nano-particles, nano-fibers, nano-tubes etc. have displayed greater competence to mimic nanoscale environment for the enzyme as compared to microand macro-environments provided by traditional support carriers that have been commonly employed for enzyme immobilization. The porous structured beads (silica, alginate etc.), membranes and fibers (>100 μm) have some inhere...